Recall Atlas
Drugs & medicalClass II

Graviti Pharmaceuticals Private Limited recalls Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti…

Failed Tablet/Capsule Specifications

Read the official notice →
Date
2025-10-29
Country
United States
Brand
Graviti Pharmaceuticals Private
Product
Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private…
Classification
Class II
Units
Product was distributed to 1 distributor and 16 wholesalers/pharmacy retailers…
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Graviti Pharmaceuticals Private recalls

  1. 2026-01-28
  2. US
    Drugs & medicalClass II

    Graviti Pharmaceuticals Private Limited recalls Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ…

    Presence of Foreign Substance

    FDA · DrugGraviti Pharmaceuticals Private LimitedU.S. NationwideOfficial notice →
All 2 Graviti Pharmaceuticals Private recalls →

Other drugs & medical recalls in the United States

  1. 2025-10-29
  2. US
    Drugs & medicalClass II

    Bristol-Myers Squibb Company recalls Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only,…

    Lack of Assurance of Sterility.

    FDA · DrugBristol-Myers Squibb CompanyNationwide in the USAOfficial notice →
  3. US
    Drugs & medicalClass II

    Lannett Company Inc. recalls Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA…

    Failed Dissolution Specifications

    FDA · DrugLannett Company Inc.Nationwide in the USAOfficial notice →
  4. US
    Drugs & medicalClass II

    Church & Dwight Co., Inc. recalls ZICAM" MEDICATED FRUIT DROPS ELDERBERRY FLAVOR, 25-drops per bottle, Distributed by: Church & Dwight Co., Inc. Ewing, NJ 08628, NDC…

    Labeling: Label Mix-up: The product in the bottle contains elderberry and the label failed to indicate the inclusion of elderberry as an ingredient.

    FDA · DrugChurch & Dwight Co., Inc.Product was distributed nationwide within the United StatesOfficial notice →
  5. US
    Drugs & medicalClass II

    Aspiro Pharma Limited recalls Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx only, Mfd. for: Camber…

    Presence of Particulate Matter: Particulate matter identified as glass

    FDA · DrugAspiro Pharma LimitedNationwide within the United StatesOfficial notice →
  6. US
    Drugs & medicalClass II

    Medline Industries, LP recalls Medline, Alcohol Prep Pads (2-Ply Pad, 70% Isopropyl Alcohol), 100 eaches per box, 10 boxes per case (1,000 eaches per case), Single Use…

    Subpotent Drug

    FDA · DrugMedline Industries, LPNationwide within the United StatesOfficial notice →
  7. US
    Drugs & medicalClass II

    USV Private Limited recalls Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton…

    Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.

    FDA · DrugUSV Private LimitedNationwide within the United StatesOfficial notice →
See all drugs & medical recalls →